RNA therapy for CF Shows Promise in Preclinical Studies, Arcturus Says

RNA therapy for CF Shows Promise in Preclinical Studies, Arcturus Says

Arcturus’ RNA Therapy for CF Shows Promise in Preclinical Studies, Company Announces

JULY 25, 2018

BY JOSE MARQUES LOPES, PHD

 

IN CYSTIC FIBROSIS, NEWS.

Arcturus Therapeutics’ RNA-based approach enables the production of healthy CFTR — the protein whose dysfunction is key in cystic fibrosis (CF) — and can be effectively delivered into lung cells, according to the company’s preclinical results. This CF treatment candidate is being developed in collaboration with Cystic Fibrosis Foundation Therapeutics, the drug discovery and development affiliate […] The post Arcturus’ RNA Therapy for CF Shows Promise in Preclinical Studies, Company Announces appeared first on Cystic Fibrosis News Today.

Read More